Chair: Pieter G. Postema, MD, PhD, Cardiology Department, Academic Medical Center, Amsterdam, The Netherlands.
Design and maintenance: Dr. Postema in collaboration with Jonas S.S.G. de Jong, MD.
This site has been registered via cardionetworks.org. The Cardionetworks Foundation is a non-profit organization based in The Netherlands and founded by Jonas S.S.G. de Jong, MD, PhD, in 2007. The goals of the Foundation are: “to improve medical knowledge, especially in the field of cardiology, and to provide access to this knowledge by facilitating publications in digital or other form, amongst other means by building and maintaining websites“. This website is published under a creative commons license. All information is freely accessible, without login or registration. You are welcome to use the information provided in your non-commercial presentations and educational materials, but we ask that you acknowledge the source.
If you have questions or remarks about this site, or when you are in need of support, please contact us.
We also welcome the submission of case reports to BrugadaDrugs.org (including ECGs) referring to new drugs or new drug-responses in Brugada syndrome. This refers to the induction of a type-1 ECG by a certain drug and/or the induction of arrhythmias, but also to the save use of a drug in a Brugada syndrome patient. The BrugadaDrugs.org Advisory Board will review your case report. If accepted, we will change the site accordingly and, if you agree, place the case report online.
Please cite this site as: Postema PG, Wolpert C, Amin AS, Probst V, Borggrefe M, Roden DM, Priori SG, Tan HL, Hiraoka M, Brugada J, Wilde AA. Drugs and Brugada syndrome patients: review of the literature, recommendations and an up-to-date website (www.brugadadrugs.org). Heart Rhythm 2009;6(9):1335-1341. (Free available from Heart Rhythm, PubMed link here).
(For the response to arrive in good order, please add brugadadrugs.org to your address book )